Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab
Year: 2006
Type: article
Study design: Observational Study
Source: Arthritis & Rheumatism
DOI: 10.1002/art.22214
Institution: Rigshospitalet
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2166771071
